Brand Name
Sular
Generic Name
Nisoldipine
View Brand Information FDA approval date: February 27, 2012
Classification: Dihydropyridine Calcium Channel Blocker
Form: Tablet
What is Sular (Nisoldipine)?
SULAR is indicated for the treatment of hypertension. It may be used alone or in combination with other anti-hypertensive agents.
Approved To Treat
Top Global Experts
Save this treatment for later
Not sure about your diagnosis?
Related Clinical Trials
There is no clinical trials being done for this treatment